Subsequently, CSC populations in brain (Singh et al, 2004), colon (O’Brien et al, 2007; Ricci-Vitiani et al, 2007), and lung (Eramo et al, 2008) cancers have also been demonstrated to reside in the CD133+ sub-population, using the xenotransplantation approach. This evidence concerns the gene PROM1 and cancer.